We are live on ! Find out more
CCM

Cullen Capital Management Portfolio holdings

AUM $9.75B
1-Year Est. Return 21.81%
This Fund
S&P 500
This Quarter Est. Return
+2.48%
1 Year Est. Return
+21.81%
3 Year Est. Return
+48.84%
5 Year Est. Return
+62.4%
10 Year Est. Return
+166.06%
AUM
$2.84B
AUM Growth
-$932K
Cap. Flow
-$69.6M
Cap. Flow %
-2.45%
Top 10 Hldgs %
28.85%
Holding
154
New
8
Increased
46
Reduced
58
Closed
14

Top Buys

Rank Stock Value
1
NVS icon
Novartis
NVS
+$7.97M
2
BCE icon
BCE
BCE
+$4.56M
3
CVX icon
Chevron
CVX
+$2.57M
4
GPC icon
Genuine Parts
GPC
+$2.44M
5
VZ icon
Verizon
VZ
+$2.22M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$41.1M
2
UN
Unilever NV New York Registry Shares
UN
+$21.7M
3
PM icon
Philip Morris
PM
+$14.6M
4
MMM icon
3M
MMM
+$12.6M
5
MO icon
Altria Group
MO
+$5.43M

Sector Composition

Rank Sector Weight
1 Financials 15.87%
2 Healthcare 14.29%
3 Industrials 11.23%
4 Technology 10.27%
5 Consumer Staples 9.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
26
Pfizer
PFE
$143B
$60.5M 2.13%
1,897,499
-137,332
-7% -$4.33M
PM icon
27
Philip Morris
PM
$309B
$58.6M 2.06%
499,129
-125,821
-20% -$14.6M
GLW icon
28
Corning
GLW
$107B
$58.4M 2.05%
1,942,365
+41,750
+2% +$1.2M
INTC icon
29
Intel
INTC
$413B
$56.5M 1.99%
1,674,135
+35,730
+2% +$1.28M
BA icon
30
Boeing
BA
$169B
$55.5M 1.95%
280,620
+5,030
+2% +$936K
HSBC icon
31
HSBC
HSBC
$352B
$51.3M 1.8%
1,209,989
+14,454
+1% +$561K
COP icon
32
ConocoPhillips
COP
$144B
$50.3M 1.77%
1,145,200
+31,560
+3% +$1.47M
LLY icon
33
Eli Lilly
LLY
$1.08T
$49.9M 1.75%
606,050
– –
RDS.B
34
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$45.7M 1.61%
840,450
+27,750
+3% +$1.54M
JCI icon
35
Johnson Controls International
JCI
$85.1B
$43.2M 1.52%
995,320
-33,937
-3% -$1.42M
DOC icon
36
Healthpeak Properties
DOC
$15.5B
$34M 1.19%
1,062,570
-97,130
-8% -$3.08M
XOM icon
37
ExxonMobil
XOM
$650B
$16.9M 0.59%
209,355
-502,360
-71% -$41.1M
IBN icon
38
ICICI Bank
IBN
$107B
$11.5M 0.4%
1,278,475
+184,800
+17% +$1.56M
TSM icon
39
TSMC
TSM
$1.94T
$10.3M 0.36%
295,950
-48,150
-14% -$1.66M
ESLT icon
40
Elbit Systems
ESLT
$36B
$8.55M 0.3%
69,310
-10,840
-14% -$1.31M
ABB
41
DELISTED
ABB Ltd
ABB
$7.93M 0.28%
318,300
– –
BTI icon
42
British American Tobacco
BTI
$136B
$6.27M 0.22%
91,490
+8,000
+10% +$556K
SBS icon
43
Sabesp
SBS
$18.4B
$6.24M 0.22%
3,379,585
-1,425,675
-30% -$2.63M
VIV icon
44
Telefônica Brasil
VIV
$20.4B
$5.1M 0.18%
377,810
-131,530
-26% -$1.89M
ABEV icon
45
Ambev
ABEV
$47.9B
$4.94M 0.17%
900,250
+315,420
+54% +$1.8M
CHL
46
DELISTED
China Mobile Limited
CHL
$4.67M 0.16%
87,900
-39,865
-31% -$2.17M
MFC icon
47
Manulife Financial
MFC
$73B
$4.64M 0.16%
247,200
-26,820
-10% -$473K
VZ icon
48
Verizon
VZ
$197B
$4.6M 0.16%
102,980
+47,630
+86% +$2.22M
TTE icon
49
TotalEnergies
TTE
$193B
$4.27M 0.15%
86,145
-6,150
-7% -$316K
PPL
50
PPL Corp
PPL
$26.9B
$4.26M 0.15%
110,300
+42,300
+62% +$1.64M
1
2
3 4

Similar funds

FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
URS
Utah Retirement Systems Salt Lake City, Utah $9.78B AUM 28.72% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
CIM
Centersquare Investment Management Conshohocken, Pennsylvania $9.67B AUM 5.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Cullen Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Cullen Capital Management held 154 positions worth $2.84B, down 0.03% from $2.85B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Cullen Capital Management's Q2 2017 filing shows 8 new, 46 increased, 58 reduced and 14 closed positions. Its largest new stake was Gilead Sciences: 8,000 shares worth $566K. The largest sale was ExxonMobil, an estimated $41.1M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.

  • Cullen Capital Management's largest Q2 2017 buy was Gilead Sciences: 8,000 shares worth $566K.
  • Cullen Capital Management added most to Novartis in Q2 2017, an estimated $7.97M increase.
  • Cullen Capital Management's biggest Q2 2017 reduction was ExxonMobil, cutting an estimated $41.1M.
  • Cullen Capital Management fully exited General Mills in Q2 2017, selling an estimated $783K.
  • Cullen Capital Management's ten largest holdings make up 29% of its $2.84B portfolio in Q2 2017.
  • Cullen Capital Management opened 8 new positions and closed 14 in Q2 2017.
  • Cullen Capital Management's portfolio value fell 0.03% quarter-over-quarter to $2.84B.

Based on Cullen Capital Management's 13F filing for Q2 2017, filed 16 Aug 2017.